Green-coffee-lipid-profile-meta-analysis: What the Evidence Says

Quick Answer

Green-coffee-lipid-profile-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• In vitro and in vivo studies demonstrate that regular coffee consumption is associated with increased glutathione levels, improved protection against DNA (deoxyribonucleic acid) damage, and reduced biomarkers of oxidative stress and inflammation. [Finta Hajnal (2026); evidence level 3]
• Epidemiological data consistently show that moderate coffee intake (typically 3-5 cups/day) is associated with reduced risk of cardiovascular disease, type 2 diabetes, neurodegenerative disorders, and certain types of cancer. [Finta Hajnal (2026); evidence level 3]
• Sensory defects are associated with inadequate practices, such as the collection of green beans, uncontrolled fermentation, drying interruptions or prolonged storage, which generate flavors such as immature, vinegary, musty, onion-like, earthy, vegetal, and papery (cardboard-like). [Gómez Claudia Rocio (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For green-coffee-lipid-profile-meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Finta Hajnal (2026). Bioactive Compounds in Coffee: Metabolism, Bioavailability and Health Effects—A Review. DOI: 10.3390/molecules31091404. PMCID: PMC13165461. PMID: 42123770. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165461/
• Gómez Claudia Rocio (2026). Near-Infrared Spectroscopy-Based Discriminant Analysis for the Classification of Coffee Quality in Dry Parchment and Green Coffee. DOI: 10.3390/molecules31091395. PMCID: PMC13165062. PMID: 42123760. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165062/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.